The present study investigated the effect of [Nphe1] Arg14, Lys15-N/OFQ-NH2 (UFP-101), a selective NOP receptor antagonist, in chronic mild stress (CMS) in male Wistar rats. NOP receptor antagonists were reported to elicit antidepressant-like effects in rodents. Our aim was to investigate UFP-101 effects on CMS-induced anhedonia and impairment of hippocampal neurogenesis. UFP-101 (10 nmol/rat intracerebroventricularly) did not influence sucrose intake in non-stressed animals, but reinstated basal sucrose consumption in stressed animals from the second week of treatment. UFP-101 also reversed stress effects in forced swimming test and in open field. Fluoxetine (10 mg/kg intraperitoneally) produced similar effects. Moreover, we investigated whether UFP-101 could affect CMS-induced impairment in hippocampal cell proliferation and neurogenesis, and in fibroblast growth factor (FGF-2) expression. Our data confirm that CMS reduced neural stem cell proliferation and neurogenesis in adult rat hippocampus. Chronic UFP-101 treatment did not affect the reduced proliferation (bromodeoxyuridine-positive cells) observed in stressed animals. However, UFP-101 increased the number of doublecortin-positive cells, restoring neurogenesis. Finally, UFP-101 significantly increased FGF-2 expression, reduced by CMS. These findings support the view that blockade of NOP receptors produces antidepressant-like effects in CMS associated with positive effects on neurogenesis and FGF-2 expression. Therefore, NOP receptors may represent a target for innovative antidepressant drugs.
AbelairaHMRéusGZQuevedoJ (2013) Animal models as tools to study the pathophysiology of depression. Rev Bras Psiquiatr35: S112–S120.
2.
AbrousDNKoehlMLe MoalM (2005) Adult neurogenesis: From precursors to network and physiology. Physiol Rev85: 523–569.
3.
AlboniSvan DijkRMPogginiS. (2016) Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment. Mol Psychiatry22: 552–561.
4.
AlderJKallmanSPalmieriA. (2013) Neuropeptide orphanin FQ inhibits dendritic morphogenesis through activation of RhoA. Dev Neurobiol73: 769–784.
5.
AlonsoRGriebelGPavoneG. (2004) Blockade of CRF1 or V-1b receptors reverses stress induced suppression of neurogenesis in a mouse model of depression. Mol Psychiatry9: 278–286.
6.
ArlettiRVitaleGRuggieriV (2005) Nociceptin/Orphanin FQ and chronic mild stress: Effect of acute and chronic treatment in the rat. 32° Congresso Nazionale della società Italiana di Farmacologia, Naples, Italy, 1–4 June, p.134. Torino: Minerva Medica.
7.
AsthLRuzzaCMalfaciniD. (2016) Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands. Neuropharmacology105: 434–442.
8.
BachisAMalleiACruzMI. (2008) Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology55: 1114–1120.
9.
BecqHJorqueraIBen-AriY. (2005) Differential properties of dentate gyrus and CA1 neural precursors. J Neurobiol62: 243–261.
10.
BessaJMMoraisMMarquesF. (2013) Stress-induced anhedonia is associated with hypertrophy of medium spiny neurons of the nucleus accumbens. Transl Psychiatry3: e266.
11.
BremnerJDNarayanMAndersonER. (2000). Hippocampal volume reduction in major depression. Am J Psychiatry157: 115–117.
12.
CalòGGuerriniRRizziA. (2005) UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor CNS. Drug Rev11: 97–112.
13.
CalòGRizziARizziD. (2002) [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br J Pharmacol136: 303–311.
14.
ChengYRodriguizRMMurthySR. (2015) Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone. Mol Psychiatry20: 744–754.
CzehBMichaelisTWatanabeT. (2001) Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA98: 12796–12801.
17.
D’AquilaPSPeanaATCarboniV. (2000) Exploratory behaviour and grooming after repeated restraint and chronic mild stress: Effect of desipramine. Eur J Pharmacol399: 43–47.
18.
de AndradeJSCéspedesICAbrãoRO. (2013) Chronic unpredictable mild stress alters an anxiety-related defensive response, Fos immunoreactivity and hippocampal adult neurogenesis. Behav Brain Res250: 81–90.
19.
De KloetERVreugdenhilEOitzlMS. (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev19: 8269–8301.
20.
DetkeMJJohnsonJLuckiI (1997) Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol5: 107–112.
21.
DetkeMJRickelsMLuckiI (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl)121: 66–72.
22.
DomecqJPPrutskyGLeppinA. (2015) Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab100: 363–370.
23.
ElsayedMBanasrMDuricV. (2012) Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression. Biol Psychiatry72: 258–265.
24.
EvansSJChoudaryPVNealCR. (2004) Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA101: 15506–15511.
25.
FirstMGil-AdITalerM. (2011) The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. J Mol Neurosci45: 246–255.
26.
FuchsECzehBFluggeG (2004) Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews. Behav Pharmacol15: 315–325.
27.
GamaroGDPredigerMELopesJ. (2008) Fluoxetine alters feeding behavior and leptin levels in chronically-stressed rats. Pharmacol Biochem Behav90: 312–317.
28.
GaughranFPayneJSedgwickPM. (2006) Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull70: 221–227.
29.
GavioliECCalòG (2006) Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. Naunyn Schmiedebergs Arch Pharmacol372: 319–330.
GavioliECMarzolaGGuerriniR. (2003) Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: Pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci17: 1987–1990.
32.
GavioliECVaughanCWMarzolaG. (2004) Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol. 369: 547–553.
33.
GeLZhuMMYangJY. (2015) Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression. Pharmacol Biochem Behav131: 77–86.
34.
GouldEMcEwenBSTanapatP. (1997) Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci17: 2492–2498.
35.
GouldETanapatPMcEwenBS. (1998) Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Nat Acad Sci USA95: 3168–3171.
36.
GrippoAJBeltzTGWeissRM. (2006) The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry59: 309–316.
37.
GuerriniRCalóGLambertDG. (2005) N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands. J Med Chem48: 1421–1427.
38.
HolandaVAMedeirosIUAsthL. (2016) Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness. Psychopharmacology233: 2525–2532.
39.
HolsboerF (2000) The stress hormone system is back on the map. Curr Psychiatry Rep2: 454–456.
40.
JayatissaMNBisgaardCFWestMJ. (2008) The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology54: 530–541.
41.
KeilhoffGBeckerAGreckschG (2006) Cell proliferation is influenced by bulbectomy and normalized by imipramine treatment in a region-specific manner. Neuropsychopharmacology31: 1165–1176.
42.
KhemissiWFarooqRKLe GuisquetAM. (2014) Dysregulation of the hypothalamus-pituitary-adrenal axis predicts some aspects of the behavioral response to chronic fluoxetine: Association with hippocampal cell proliferation. Front Behav Neurosci8: 340.
43.
KilkennyCBrowneWJCuthillIC. (2010) Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother1: 94–99.
44.
KlompAVáclavuLMeerhoffGF. (2014) Effects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult rats. PLoS One9: e97603.
45.
KuhnHGWinklerJKempermannG. (1997) Epidermal growth factor and fibroblast growth factor-2 have differ neural progenitors in the adult rat brain. J Neurosci17: 5820–5829.
46.
LiYCWangFMPanY. (2009) Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry33: 435–449.
47.
LledoPMAlonsoMGrubbMS (2006) Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci7: 179–193.
48.
López-RubalcavaCLuckiI (2000) Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology22: 191–199.
49.
MalbergJEDumanRS (2003) Cell proliferation in adult hippocampus is decreased by inescapable stress: Reversal by fluoxetine treatment. Neuropsychopharmacology28: 1562–1571.
50.
MalbergJESchechterLE (2005) Increasing hippocampal neurogenesis: A novel mechanism for antidepressant drugs. Curr Pharm Des11: 145–155.
51.
MalbergJEEischAJNestler. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci20: 9104–9110.
52.
MalleiAShiBMocchettiI (2002) Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol Pharmacol61: 1017–1024.
53.
MarcussenABFlagstadPKristjansenPEG. (2008) Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats. Acta Neurol Scand117: 94–100.
54.
MazzuferiMPalmaEMartinelloK. (2010) Enhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy. Proc Natl Acad Sci USA107: 3180–3185.
55.
McEwenBS (1999) Stress and hippocampal plasticity. Annu Rev Neurosci22: 105–122.
56.
McEwenBSSapolskyRM (1995) Stress and cognitive function. Curr Opin Neurobiol5: 205–216.
57.
McGuirkJMuscatRWillnerP (1992) Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology (Berl)106: 401–407.
58.
MedeirosIURuzzaCAsthL. (2015) Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice. Peptides72: 95–103.
59.
MurataYYanagiharaYMoriM. (2015) Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior. J Affect Disord180: 1–9.
60.
NakatomiHKuriuTOkabeS. (2002) Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell110: 429–441.
61.
NibuyaMMorinobuSDumanRS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci15: 7539–7547.
PalmerTDMarkakisEAWillhoiteAR. (1999) Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci19: 8487–8497.
64.
ParadisoBMarconiPZucchiniS. (2009) Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci USA106: 7191–7196.
65.
ParianteCMLightmanSL (2008) The HPA axis in major depression: Classical theories and new developments. Trends Neurosci31: 464–468.
66.
PaxinosGWatsonC (2005) The Rat Brain in Stereotaxic Coordinates, 5th ed.New York: Academic Press.
67.
Perez-CaballeroLTorres-SanchezSBravoL. (2014) Fluoxetine: A case history of its discovery and preclinical development. Expert Opin Drug Discov9: 567–578.
68.
PinnockSBLazicSEWongHT. (2009) Synergistic effects of dehydroepiandrosterone and fluoxetine on proliferation of progenitor cells in the dentate gyrus of the adult male rat. Neuroscience 158: 1644–1651.
69.
PlümpeTEhningerDSteinerB. (2006) Variability of doublecortin-associated dendrite maturation in adult hippocampal neurogenesis is independent of the regulation of precursor cell proliferation. BMC Neurosci7: 77.
70.
PorsoltRDAntonGBlavetN. (1978) Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol47: 379–391.
71.
PorsoltRDLe PichonMJalfreM (1977) Depression: A new animal model sensitive to antidepressant treatments. Nature266: 730–732.
72.
PossamaiFdos SantosJWalberT. (2015) Influence of enrichment on behavioral and neurogenic effects of antidepressants in Wistar rats submitted to repeated forced swim test. Prog Neuropsychopharmacol Biol Psychiatry58: 15–21.
73.
PostASmartTSKrikke-WorkelJ. (2016) A selective nociceptin receptor antagonist to treat depression: Evidence from preclinical and clinical studies. Neuropsychopharmacology41: 1803–1812.
74.
RizziAGavioliECMarzolaG. (2007) Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies. J Pharmacol Exp Ther321: 968–974.
75.
SantarelliLSaxeMGrossC. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science301: 805–809.
76.
SapolskyRM (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry57: 925–935.
77.
SchuldASchmidDAHaackM. (2003) Hypothalamo–pituitary–adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone. J Psychiatr Res37: 463–470.
78.
ShelineYIGadoMHKraemerHC (2003) Untreated depression and hippocampal volume loss. Am J Psychiatry160: 1516–1518.
79.
TanapatPGaleaLAGouldE (1998) Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus. Int J Dev Neurosci16: 235–239.
80.
TollLBruchasMRCalòG. (2016) Nociceptin/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev68: 419–457.
81.
TurnerCAAkilHWatsonSJ. (2006) The fibroblast growth factor system and mood disorders. Biol Psychiatry59: 1128–1135.
82.
Van der HartMGCCzehBde BiurrunG. (2002) Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol Psychiatry7: 933–941.
83.
VitaleGRuggieriVFilaferroM. (2009) Chronic treatment with the selective NOP receptor antagonist [Nphe1, Arg14, Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats. Psychopharmacology (Berl)207: 173–189.
WillnerP (1997) Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology134: 319–329.
86.
WillnerP (2005) Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology52: 90–110.
87.
WillnerPMuscatRPappM (1992) Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci Biobehav Rev16: 525–534.
88.
WitkinJMStatnickMARorick-KehnLM. (2014) The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacol Ther141: 283–299.
89.
YunSDonovanMHRossMN. (2016) Stress-induced anxiety- and depressive-like phenotype associated with transient reduction in neurogenesis in adult nestin-CreERT2/Diphtheria toxin fragment a transgenic mice. PLoS One11: e0147256.
90.
ZhaoJJungYHJangCG. (2015a) Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression. Sci Rep5: 8890.
91.
ZhaoLXiongZLuX. (2015b) Metabonomic evaluation of chronic unpredictable mild stress-induced changes in rats by intervention of fluoxetine by HILIC-UHPLC/MS. PLoS One10: e0129146.
92.
ZucchiniSBuzziABarbieriM. (2008) FGF-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss. J Neurosci28: 13112–13124.
